IT

Anne Decor

This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne Decor. Retrieved from https://idiyas.com/inventor/anne-decor-7u85uq63

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Anne Decor: Innovator in Kv3 Inhibitors

Introduction

Anne Decor is a notable inventor based in Italy, recognized for her contributions to the field of pharmaceuticals. She has focused her research on developing innovative compounds that serve as inhibitors for Kv3 channels, which are crucial in treating various disorders.

Latest Patents

Anne Decor holds two significant patents. The first is titled "Hydantoin Derivatives Useful As Kv3 Inhibitors." This invention provides compounds of formula (I), which are identified as inhibitors of Kv3 channels and are intended for use in the prophylaxis or treatment of related disorders. The second patent is for "Imidazolidinedione Derivatives." This invention offers a compound of formula (Ia) and pharmaceutically acceptable salts thereof. It also details the use of these compounds or salts as modulators of Kv3.1 and/or Kv3.2, targeting diseases or disorders such as depression, mood disorders, hearing disorders, schizophrenia, substance abuse disorders, sleep disorders, or epilepsy.

Career Highlights

Anne Decor is currently employed at Autifony Therapeutics Limited, where she continues to advance her research in pharmacology. Her work is pivotal in developing new therapeutic options for patients suffering from various neurological and psychiatric conditions.

Collaborations

Some of her notable coworkers include Giuseppe Alvaro and Paolo Dambruoso, who contribute to her research endeavors and collaborative projects.

Conclusion

Anne Decor is a pioneering inventor whose work on Kv3 inhibitors has the potential to significantly impact the treatment of several disorders. Her innovative approach and dedication to research exemplify the spirit of invention in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…